121 related articles for article (PubMed ID: 6756707)
21. [Significance of brain renin for pathogenesis of hypertension: effect of antihypertensive drugs on active and inactive renins in the brain of spontaneously hypertensive rat].
Watari H
Nihon Naibunpi Gakkai Zasshi; 1989 Jan; 65(1):66-78. PubMed ID: 2656313
[TBL] [Abstract][Full Text] [Related]
22. Prediction of sustained antihypertensive efficacy of chronic captopril therapy: relationships to immediate blood pressure response and control plasma renin activity.
Waeber B; Gavras I; Brunner HR; Cook CA; Charocopos F; Gavras HP
Am Heart J; 1982 Mar; 103(3):384-90. PubMed ID: 6278905
[TBL] [Abstract][Full Text] [Related]
23. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.
Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA
Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579
[TBL] [Abstract][Full Text] [Related]
24. Participation of the renin system in treatment-resistant hypertension as measured by acute blockade of the angiotensin converting enzyme.
Weber MA; Drayer JI; Priest RT; Chen TC
Am J Nephrol; 1982; 2(1):6-11. PubMed ID: 6295161
[TBL] [Abstract][Full Text] [Related]
25. Influence of indomethacin on the natriuretic and renin-stimulating effect of bumetanide in essential hypertension.
Pedrinelli R; Magagna A; Arzilli F; Sassano P; Salvetti A
Clin Pharmacol Ther; 1980 Dec; 28(6):722-31. PubMed ID: 7002429
[TBL] [Abstract][Full Text] [Related]
26. Hormonal responses to long-term converting enzyme inhibition in hypertensive patients.
Ogihara T; Maruyama A; Hata T; Mikami H; Nakamaru M; Naka T; Ohde H; Kumahara Y
Clin Pharmacol Ther; 1981 Sep; 30(3):328-35. PubMed ID: 6268347
[TBL] [Abstract][Full Text] [Related]
27. Atenolol administered once daily in primary hypertension. Effects on blood pressure in relation to pre-treatment plasma renin activity.
Nilsson OR; Karlberg BE; Ohlsson O; Thulin T; Tolagen K
Acta Med Scand; 1979; 206(4):303-8. PubMed ID: 506802
[TBL] [Abstract][Full Text] [Related]
28. Evidence that the beta-adrenergic system and prostaglandins stimulate renin release through different mechanisms.
Hsueh WA; Goldstone R; Carlson EJ; Horton R
J Clin Endocrinol Metab; 1985 Sep; 61(3):399-403. PubMed ID: 2991316
[TBL] [Abstract][Full Text] [Related]
29. Acute hypotensive effect of captopril in man modified by prostaglandin synthesis inhibition.
Silberbauer K; Stanek B; Templ H
Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):87S-93S. PubMed ID: 6753910
[TBL] [Abstract][Full Text] [Related]
30. [Efficacy and tolerability of a cardioselective beta-blocking drug (atenolol) in the treatment of essential hypertension. A double blind study (author's transl)].
Rengo F; Trimarco B; Petretta M; Ferrara N; Bonaduce D; Chiariello M; Condorelli M
G Ital Cardiol; 1978; 8(8):861-7. PubMed ID: 359398
[TBL] [Abstract][Full Text] [Related]
31. Sustained antihypertensive effect of captopril combined with diuretics and beta-adrenergic blocking drugs in patients with resistant hypertension.
Forslund T; Fyhrquist F; Hortling L
Acta Med Scand; 1983; 213(4):299-303. PubMed ID: 6137132
[TBL] [Abstract][Full Text] [Related]
32. Long-term effects of captopril and atenolol in essential hypertension.
Andrén L; Karlberg BE; Svensson A; Ohman P; Nilsson OR; Hansson L
Acta Med Scand; 1985; 217(2):155-60. PubMed ID: 3887847
[TBL] [Abstract][Full Text] [Related]
33. Long-term efficacy of captopril in renovascular and essential hypertension.
Case DB; Atlas SA; Marion RM; Laragh JH
Am J Cardiol; 1982 Apr; 49(6):1440-6. PubMed ID: 6803561
[TBL] [Abstract][Full Text] [Related]
34. Antihypertensive effect of the oral angiotensin I-converting enzyme inhibitor in long-term treatment of hypertensive patients.
Mizuno K; Gotoh M; Matsui J; Fukuchi S
Jpn Heart J; 1981 Nov; 22(6):903-13. PubMed ID: 7040724
[TBL] [Abstract][Full Text] [Related]
35. Circulatory effects of renin-angiotensin system antagonists during halothane anaesthesia in hypertensive rats.
Kaukinen S; Kataja J; Ylitalo P
Acta Anaesthesiol Scand; 1983 Feb; 27(1):81-6. PubMed ID: 6340406
[TBL] [Abstract][Full Text] [Related]
36. Urinary 6-keto-PGF1 alpha after captopril and indomethacin: possible contribution of PGI2 to the antihypertensive mechanism of ACE inhibitors.
Minuz P; Degan M; Covi G; Lechi C; Velo GP; Lechi A
Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():199-202. PubMed ID: 2988309
[No Abstract] [Full Text] [Related]
37. Different mechanisms maintaining high blood pressure in chronic one-kidney, one-clip, and two-kidney, one-clip hypertensive rats.
Hashimoto H; Hiwada K; Kokubu T
Clin Exp Hypertens A; 1983; 5(3):429-45. PubMed ID: 6188560
[TBL] [Abstract][Full Text] [Related]
38. Humoral and hemodynamic effects of increasing doses of captopril in patients with essential hypertension.
Sassano P; Pedrinelli R; Magagna A; Abdel-Haq B; Salvetti A
Am J Cardiol; 1982 Apr; 49(6):1574-6. PubMed ID: 6280486
[TBL] [Abstract][Full Text] [Related]
39. Predicting interindividual variations in antihypertensive therapy: the role of sodium transport systems and renin.
Niutta E; Cusi D; Colombo R; Pellizzoni M; Cesana B; Barlassina C; Soldati L; Bianchi G
J Hypertens Suppl; 1990 Sep; 8(4):S53-8. PubMed ID: 2175354
[TBL] [Abstract][Full Text] [Related]
40. [Inhibition of the angiotensin I converting enzyme with SQ-14225 (captopril) in the medical treatment of severe renovascular hypertension].
Martínez Amenós A; Caralps A; Rama H; Sarrias X; Alsina J
Rev Clin Esp; 1981 Sep; 162(6):265-8. PubMed ID: 7036249
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
